Unlocking the power of the immune system
About
Polyceutix
Our goal is to cure muscle-invasive bladder cancer using AASTY-TLR a novel immunomodulatory compound, invented at the interface of materials science, and immunology. AASTY-TLR is a copolymer injected into tumors, where it solubilizes lipid bilayers and membrane proteins therein into polymer-lipid particles. This releases cancer neoantigens in solubilized form, which immune cells uptake, triggering an adaptive anti-tumor response. The TLR agonist attached to each copolymer further amplifies immune activation, creating a powerful therapeutic effect.
Polyceutix is a spinout from the Technical University of Denmark (DTU).
Supported by:
Contact Us
Interested in working together? Fill out your info and we will be in touch shortly. We can’t wait to hear from you!